Emerald Health Therapeutics, Inc. has launched its new product line, SYNC Tabs, an innovative, naturally-flavoured ingestible offering consumers a controlled 10 mg THC dose with predictable onset and offset. This product line expands its offering under its SYNC Wellness brand and is the second of Emerald's Defined Dose products. Emerald's Cannabis 2.0 and 3.0 strategy focuses on leveraging science-based innovation to serve targeted consumer preferences. This differentiated new product line builds on Emerald's commitment to offering consumers defined dosing and predictable actions that let them control their cannabis consumption experience. SYNC Tabs are designed in a familiar tablet form that enables convenient yet discreet cannabis use. With 10 mg of THC, SYNC™ Tabs offer consumers the measured stringency of Emerald's Defined Dose™ standard, dissolve under the tongue in about three minutes, and provide desired effects within 20 to 30 minutes. Offset is equally controlled, occurring within approximately 90 minutes of taking the tablet. This new product line follows the introduction of Emerald's Nano Fast-Acting Spray product. Sublingual tablets add to the SYNC™ brand's line-up of non-smoking forms of cannabis products, which also include CBD and THC cannabis oils. Designed to serve customers' use of cannabis for daily wellness routines, SYNC™ Tabs are sugar-free, gluten-free, vegan and come in two natural flavours, cherry and mint. Produced with 100% coconut-derived MCT oil, the products offer a sustainably-produced cannabis wellness option. Each pack contains 10 x 10 mg doses, offering 100 mg of THC in total.